Question
Suppose you are tasked with evaluating the merits of a new prostate cancer treatment regimen relative to the current treatment regimen on behalf of a
Suppose you are tasked with evaluating the merits of a new prostate cancer treatment regimen relative to the current treatment regimen on behalf of a US health insurance company. Given the information below, answer the questions that follow.
CostResult
Current Treatment$50,0004 life-years gained
New Treatment$75,0005 life-years gained
a)Which treatment is more effective in terms of prolonging life? Why?
b)Which treatment is more cost-effective in terms of prolonging life? Why? Show your calculations.
c)Now assume that the new treatment has far fewer side-effects than the current treatment. As a result, the average QALY weight per life-year gained is 0.8 for the new treatment, compared to 0.5 for the current treatment. Which treatment is more cost-effective in terms of quality-adjusted life-years gained? Why? Show your calculations.
d)Would the new treatment be considered acceptably cost-effective, given commonly used QALY thresholds in the US? Why or why not?
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started
Macroeconomics Principles Applications And Tools
Authors: Arthur O Sullivan, Steven M. Sheffrin, Stephen J. Perez
7th Edition
978-0134089034, 9780134062754, 134089030, 134062752, 978-0132555234
